HOME
Leading the way to a cure

Lupus Research Update: 2014 Volume 1

Volume 1, 2014 | In This Issue


Diagnosing Lupus: A Physician’s Point of View >
Lupus Research to Better Treat and Diagnose Patients >
The Unique Role of Rheumatologists >
A Loving Family Battles Lupus Together >
2014 ALR Grantees Announced >
Lupus News Corner >

2014 ALR Grantees Announced

The following 13 world-renowned investigators recently received ALR Target Identification in Lupus (TIL) grants to brings their ideas to fruition - and uncover new treatments and cures for people living with the disease.

Marta E. Alarcon-Riquelme, MD, PhD
Fundación Pública Andaluza Progreso y Salud
Sevilla, Spain
Influence of BANK1 in the In Vivo Development of Lupus

Paolo Casali, MD
University of Texas Health Science Center
San Antonio, TX
B cell histone modifications and noncoding RNA as targets in lupus therapy

Philip Cohen, MD
Temple University
Philadelphia, PA
Aggregated MAVS as a Disease Mechanism in SLE

Loren D. Erickson, PhD
University of Virginia
Charlottesville, VA
The Role of BAFF Receptor BCMA to Control B Cell Homeostasis and Tolerance

Chaim Oscar Jacob, MD, PhD
University of Southern California
Los Angeles, CA
Understanding the Role of NCF2 in SLE

Theresa T. Lu, MD, PhD – Jean Davis Research Grant Recipient
The Hospital for Special Surgery
New York, NY
Targeting a Dendritic Cell-stromal Axis in Lupus

Chandra Mohan, MD, PhD
University of Houston
Houston, TX
Bradykinins in Lupus

Erik Jon Peterson, MD
University of Minnesota
Twin Cities, MN
Targeting Interferogenic Signals Regulated by SLE Risk Gene PTPN22

Laurence Morel, PhD and Derry Roopenian, PhD
University of Florida               Jackson Laboratories
Gainesville, FL                       Bar Harbor, FL
High Throughput Screening to Repurpose Drugs for Lupus Therapies

Jeffery C. Rathmell, PhD
Duke University Medical Center
Durham, NC
Metabolism of Effector T cells as a Target in SLE

Kathleen Sullivan, MD, PhD
The Children’s Hospital of Philadelphia
Philadelphia, PA
IRF1 Decoy Treatment

Edward K. Wakeland, PhD
UT Southwestern Medical Center
Dallas, TX
Identifying Functional Variants that Underlie SLE Susceptibility


1.5 million

people in the U.S. have Lupus.

172 million

dollars committed to lupus research by the Lupus Research Alliance.


We're walking across the United States to raise awareness and funds for lupus research.

 

Show your support by visiting the Lupus Research Alliance online store. Discover the perfect gift, or prepare for a walk with our selection of apparel and accessories.

Powered by Blackbaud
nonprofit software